Cited by 510Memory and Neural MechanismsPosttraumatic Stress Disorder ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy

Norberg, Melissa M., Krystal, John H., Tolin, David F.·2008·Biological Psychiatry

DOI 10.1016/j.biopsych.2008.01.012

Open this paper in CoChat — free account

Abstract

Background Translational research suggests that D-cycloserine (DCS), a partial N-methyl-D-aspartate (NMDA) receptor agonist, might facilitate fear extinction and exposure therapy by either enhancing NMDA receptor function during extinction or by reducing NMDA receptor function during fear memory consolidation. This article provides a quantitative review of DCS-augmented fear extinction and exposure therapy literature.Methods English-language journal articles that examined DCS augmented with fear extinction or exposure therapy were identified through public databases from June 1998 through September 2007, through references of originally identified articles and contact with DCS investigators. Data were extracted for study author, title, and year; trial design; type of subject (animal vs. human; clinical vs. nonclinical); sample size, DCS dose, and timing in relation to extinction/exposure procedures; dependent variable; group means and SDs at post-extinction/exposure; and follow-up outcome.Results D-cycloserine enhances fear extinction/exposure therapy in both animals and anxiety-disordered humans. Gains generally were maintained at follow-up, although some lessening of efficacy was noted. D-cycloserine was more effective when administered a limited number of times and when given immediately before or after extinction training/exposure therapy.Conclusions This meta-analysis suggests that DCS is a useful target for translational research on augmenting exposure-based treatment via compounds that impact neuroplasticity. D-cycloserine 's major contribution to exposure-based therapy might be to increase its speed or efficiency, because the effects of DCS seem to decrease over repeated sessions. This information might guide translational researchers in discovering more selective and/or effective agents that effectively enhance (or reduce) NMDA receptor function.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2008.01.012

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Meta-Analytic Procedures for Social Research
Rosenthal, R. (1991) · doi:10.4135/9781412984997 · Cited by 4,635
Meta-Analytic Procedures for Social Research.
Metcalfe, A., & Rosenthal, R. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348600 · Cited by 4,249
Meta-analysis in social research
(1982) · Evaluation and Program Planning · doi:10.1016/0149-7189(82)90011-8 · Cited by 3,896
Development and validation of measures of social phobia scrutiny fear and social interaction anxiety11Editor’s note: This article was written before the development of some contemporary measures of social phobia, such as the Social Phobia and Anxiety Inventory (Turner et al., 1989). We have invited this article for publication because of the growing interest in the scales described therein. S.T.
Mattick, R. P., & Clarke, J. C. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10031-6 · Cited by 3,367
The practice of behavior therapy
Wolpe, J. (1969) · Cited by 2,343
The Yale-Brown Obsessive-Compulsive Scale: measures of internal consistency.
Kim, S.-W., Dysken, M., Pheley, A., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,333
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Flagged first, then by citations

Show all 121 references

Research works printed but not linked: 1

Ledgerwood, 2004, D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement, Behav Neurosci, 118, 505, 10.1037/0735-7044.118.3.505 · DOI

Sorted by citations

Items 101–200 of 509

D-Cycloserine Facilitation of Fear Extinction and Exposure-Based Therapy Might Rely on Lower-Level, Automatic Mechanisms
Grillon, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.017 · Cited by 80
“DCS levels peak four to eight hours after oral administration, which corresponds to the peak period of post-extinction memory consolidation in these studies (73).”
Influential
Towards new approaches to disorders of fear and anxiety
Dias, B. G., Banerjee, S. B., Goodman, J. V., & Ressler, K. J. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.013 · Cited by 79
From lab to clinic: Extinction of cued cravings to reduce overeating
Jansen, A. T. M., Schyns, G., Bongers, P., & van den Akker, K. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.03.018 · Cited by 83
Fear conditioning and extinction in obsessive-compulsive disorder: A systematic review
Cooper, S. E., & Dunsmoor, J. E. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.026 · Cited by 83
Structural Determinants and Mechanism of Action of a GluN2C-selective NMDA Receptor Positive Allosteric Modulator
Khatri, A., Burger, P. B., Swanger, S. A., Hansen, K. B., Zimmerman, S. S., Karakaş, E., Liotta, D. C., Furukawa, H., Snyder, J. P., & Traynelis, S. F. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094516 · Cited by 82
Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain
Forsyth, J. K., Bachman, P., Mathalon, D. H., Roach, B. J., & Asarnow, R. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509262112 · Cited by 80
Human Extinction Learning Is Accelerated by an Angiotensin Antagonist via Ventromedial Prefrontal Cortex and Its Connections With Basolateral Amygdala
Zhou, F., Geng, Y., Xin, F., Li, J., Feng, P., Liu, C., Zhao, W., Feng, T., Guastella, A. J., Ebstein, R. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.007 · Cited by 70
Modulation of fear extinction processes using transcranial electrical stimulation
Abend, R., Jalon, I., Gurevitch, G., Sar-El, R., Shechner, T., Pine, D. S., Hendler, T., & Bar‐Haim, Y. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.197 · Cited by 80
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
Krystal, J. H., Tolin, D. F., Sanacora, G., Castner, S. A., Williams, G. V., Aikins, D. E., Hoffman, R. E., & D'Souza, D. C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.002 · Cited by 76
Self-citation
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
Whittle, N., Schmuckermair, C., Gunduz‐Cinar, O., Hauschild, M., Ferraguti, F., Holmes, A., & Singewald, N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.001 · Cited by 76
Augmentation of exposure therapy with post-session administration of D-cycloserine
Tart, C. D., Handelsman, P. R., DeBoer, L. B., Rosenfield, D., Pollack, M. H., Hofmann, S. G., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.024 · Cited by 75
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 75
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia
Gottlieb, J. D., Cather, C., Shanahan, M., Creedon, T., Macklin, E. A., & Goff, D. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.029 · Cited by 73
New Modalities of Assessment and Treatment Planning in Depression
Fava, G. A., & Tomba, E. (2010) · CNS Drugs · doi:10.2165/11531580-000000000-00000 · Cited by 76
A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders
Minshawi, N. F., Wink, L. K., Shaffer, R. C., Plawecki, M. H., Posey, D. J., Liu, H., Hurwitz, S., McDougle, C. J., Swiezy, N. B., & Erickson, C. A. (2016) · Molecular Autism · doi:10.1186/s13229-015-0062-8 · Cited by 75
Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans
Klumpers, F., Denys, D., Kenemans, J. L., Grillon, C., van der Aart, J., & Baas, J. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431624 · Cited by 72
D-Cycloserine Effects on Extinction of Conditioned Responses to Drug-Related Cues
Myers, K. M., & Carlezon, W. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.030 · Cited by 72
Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala
Alvarez-Dieppa, A. C., Griffin, K., Cavalier, S., & McIntyre, C. K. (2016) · Neural Plasticity · doi:10.1155/2016/4273280 · Cited by 69
Randomized Placebo-Controlled D-Cycloserine with Cognitive Behavior Therapy for Pediatric Posttraumatic Stress
Scheeringa, M. S., & Weems, C. F. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0106 · Cited by 72
Pharmacological Discrimination of Extinction and Reconsolidation of Contextual Fear Memory by a Potentiator of AMPA Receptors
Yamada, D., Zushida, K., Wada, K., & Sekiguchi, M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.86 · Cited by 72
d-Cycloserine augmentation of cognitive remediation in schizophrenia
Cain, C. K., McCue, M. G., Bello, I., Creedon, T. B., Tang, D., LASKA, E. M., & GOFF, D. C. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.016 · Cited by 75
Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions
Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., van Minnen, A., Evins, A. E., & Pollack, M. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.007 · Cited by 70
Self-citation
Cognitive Behavior Therapy for Obsessive-Compulsive and Related Disorders
Lewin, A. B., Wu, M. S., Mcguire, J. F., & Storch, E. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.002 · Cited by 73
d-Cycloserine Augmentation of Behavioral Therapy for the Treatment of Anxiety Disorders: A Meta-Analysis
Bontempo, A., Panza, K. E., & Bloch, M. H. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07356 · Cited by 69
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
Raut, S. B., Marathe, P. A., van Eijk, L., Eri, R. D., Ravindran, M., Benedek, D. M., Ursano, R. J., Canales, J. J., & Johnson, L. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108195 · Cited by 74
The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders
Peyrovian, B., Rosenblat, J. D., Pan, Z., Iacobucci, M., Brietzke, E. M., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.001 · Cited by 76
Cognitive enhancers for anxiety disorders
Hofmann, S. G., Smits, J. A. J., Asnaani, A., Gutner, C. A., & Otto, M. W. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.020 · Cited by 69
Evidenced-Based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches
Charney, M. E., Hellberg, S. N., Bui, É., & Simon, N. M. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000186 · Cited by 68
Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder
Matsumoto, Y., Morinobu, S., Yamamoto, S., Matsumoto, T., Takei, S., Fujita, Y., & Yamawaki, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3078-9 · Cited by 70
Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review
de Kleine, R. A., ROTHBAUM, B. O., & van Minnen, A. (2013) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v4i0.21626 · Cited by 72
Augmentation of Cognitive Behavioral Therapy with Pharmacotherapy
Ganasen, K. A., Ipser, J., & Stein, D. J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.008 · Cited by 68
Treatment of Pediatric Obsessive-Compulsive Disorder: A Review
Mancuso, E., Faro, A. L., Joshi, G., & GELLER, D. A. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0040 · Cited by 67
Effects of d-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial
Kiefer, F., Kirsch, M., Bach, P., Hoffmann, S., Reinhard, I., Jorde, A., von der Goltz, C., Spanagel, R., Mann, K. F., Loeber, S., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3882-5 · Cited by 68
A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder
Stein, D. J., Koen, N., Fineberg, N., Fontenelle, L. F., Matsunaga, H., Osser, D., & Simpson, H. B. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0268-9 · Cited by 65
Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder
Askari, N., Moin, M., Sanati, M. H., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Najand, B., Salimi, S., Tabrizi, M. H., Ashrafi, M., et al. (2012) · CNS Drugs · doi:10.2165/11635850-000000000-00000 · Cited by 65
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder
GELLER, D. A., & March, J. S. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.3.360 · Cited by 64
Cognitive–behavioural therapy with post-session d-cycloserine augmentation for paediatric obsessive–compulsive disorder: pilot randomised controlled trial
Mataix‐Cols, D., Turner, C. M., Monzani, B. A., Isomura, K., Murphy, C., Krebs, G., & Heyman, I. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126284 · Cited by 64
Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
Guercio, G. D., & Panizzutti, R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00014 · Cited by 67
Extinction theory & anorexia nervosa: Deepening therapeutic mechanisms
Murray, S. B., Treanor, M., Liao, B., Loeb, K. L., Griffiths, S., & Le Grange, D. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.08.017 · Cited by 60
Pharmacotherapy for anxiety disorders in children and adolescents
Kodish, I., Rockhill, C., & Varley, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/ikodish · Cited by 62
Psychopharmacological Issues in the Treatment of TBI and PTSD
McAllister, T. W. (2009) · The Clinical Neuropsychologist · doi:10.1080/13854040903277289 · Cited by 62
Therapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder
Schmidt, U., Herrmann, L., Hagl, K., Novak, B., Huber, C. W., Holsboer, F., Wotjak, C. T., & Buell, D. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00066 · Cited by 62
Deepened extinction following compound stimulus presentation: Noradrenergic modulationPreprint
Janak, P. H., & Corbit, L. H. (2010) · Learning & Memory · doi:10.1101/lm.1923211 · Cited by 61
d-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-11 · Cited by 59
Eating in eating disorders
Treasure, J. L., Cardi, V., & Kan, C. (2011) · European Eating Disorders Review · doi:10.1002/erv.1090 · Cited by 63
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder
McGuire, J. F., Lewin, A. B., & Storch, E. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.934677 · Cited by 57
“Beyond promoting the extinction of conditioned fear [27,28], there is some evidence to suggest that DCS also facilitates the consolidation of fear learning associated with extinction training [29].”
Background
Modafinil combined with cognitive training: Pharmacological augmentation of cognitive training in schizophrenia
Michalopoulou, P. G., Lewis, S. W., Drake, R., Reichenberg, A., Emsley, R., Kalpakidou, A. K., Lees, J., Bobin, T., Gilleen, J., Pandina, G., et al. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.009 · Cited by 57
Neuropharmacological Modulation of N-methyl-D-aspartate, Noradrenaline and Endocannabinoid Receptors in Fear Extinction Learning: Synaptic Transmission and Plasticity
Battaglia, S., Fazio, C. D., Vicario, C. M., & Avenanti, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065926 · Cited by 56
d-Cycloserine Facilitates Extinction of Conditioned Alcohol-Seeking Behaviour in Rats
Vengeliene, V., Kiefer, F., & Spanagel, R. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn067 · Cited by 57
The Role of Serine Racemase in the Pathophysiology of Brain Disorders
Coyle, J. T., & Balu, D. T. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.10.002 · Cited by 58
d-Cycloserine Facilitation of Exposure Therapy Improves Weight Regain in Patients With Anorexia Nervosa: A Pilot Randomized Controlled Trial
Levinson, C. A., Rodebaugh, T. L., Fewell, L., Kass, A. E., Riley, E. N., Stark, L., McCallum, K., & Lenze, E. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09299 · Cited by 56
d-serine enhances extinction of auditory cued fear conditioning via ERK1/2 phosphorylation in mice
Matsuda, S., Matsuzawa, D., Nakazawa, K., Sutoh, C., Ohtsuka, H., Ishii, D., Tomizawa, H., Iyo, M., & Shimizu, E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.013 · Cited by 57
A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans
Grillon, C., & Ernst, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.024 · Cited by 52
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 57
Impaired fear extinction in adolescent rodents: Behavioural and neural analyses
Baker, K., Bisby, M. A., & Richardson, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.019 · Cited by 60
Effect of d-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial
Kuriyama, K., Honma, M., Soshi, T., Fujii, T., & Kim, Y. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2353-x · Cited by 54
Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people
Sahakian, B. J., & Morein‐Zamir, S. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00004-8 · Cited by 55
A randomized, placebo-controlled laboratory study of the effects of d-cycloserine on craving in cocaine-dependent individuals
Price, K. L., Baker, N. L., McRae‐Clark, A. L., Saladin, M. E., DeSantis, S. M., Ana, E. J. S., & Brady, K. T. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2592-x · Cited by 55
Early stress exposure impairs synaptic potentiation in the rat medial prefrontal cortex underlying contextual fear extinction
Judo, C., Matsumoto, M., Yamazaki, D., Hiraide, S., Yanagawa, Y., Kimura, S., Shimamura, K., & Togashi, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.035 · Cited by 52
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis
Rosenfield, D., Smits, J. A. J., Hofmann, S. G., Mataix‐Cols, D., de la Cruz, L. F., Andersson, E., Rück, C., Monzani, B. A., Pérez-Vigil, A., Frumento, P., et al. (2019) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2019.102149 · Cited by 52
Self-citation
Obsessive-compulsive disorder: Evidence-based treatments and future directions for research
Lack, C. W. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.86 · Cited by 52
A Meta-Analysis of d-Cycloserine in Exposure-Based Treatment
Mcguire, J. F., Wu, M. S., Piacentini, J. C., McCracken, J. T., & Storch, E. A. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15r10334 · Cited by 52
Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: A morphometric study
Fullana, M. A., Cardoner, N., Alonso, P., Subirà, M., López-Solà, C., Pujol, J., Segalàs, C., Real, E., Bossa, M., Zacur, E., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291713001128 · Cited by 50
Primary Process Affects and Brain Oxytocin
Panksepp, J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.004 · Cited by 50
Interoception and Learning: Import to Understanding and Treating Diseases and Psychopathologies
Bevins, R. A., & Besheer, J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5001028 · Cited by 49
Restoration of Synaptic Plasticity and Learning in Young and Aged NCAM-Deficient Mice by Enhancing Neurotransmission Mediated by GluN2A-Containing NMDA Receptors
Kochlamazashvili, G., Bukalo, O., Senkov, O., Salmen, B., Gerardy‐Schahn, R., Engel, A. K., Schachner, M., & Dityatev, A. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-11.2012 · Cited by 49
Mechanisms Underlying Behavior Therapy for Tourette’s Disorder
Essoe, J. K.-Y., Ramsey, K. A., Singer, H. S., Grados, M. A., & Mcguire, J. F. (2021) · Current Developmental Disorders Reports · doi:10.1007/s40474-021-00225-1 · Cited by 48
Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation
Kumar, A., Mehan, S., Tiwari, A., Khan, Z., Gupta, G. D., Narula, A. S., & Samant, R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128321466240816075041 · Cited by 55
Emotion classification using single-channel scalp-EEG recording
Jalilifard, A., Pizzolato, E. B., & Islam, M. K. (2016) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7590833 · Cited by 47
Pharmacological Enhancement of Behavioral Therapy: Focus on Posttraumatic Stress Disorder
Choi, D. C., ROTHBAUM, B. O., Gerardi, M. A., & Ressler, K. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_10 · Cited by 47
Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive–Compulsive Disorder?
Park, J. M., Small, B. J., GELLER, D. A., Murphy, T. K., Lewin, A. B., & Storch, E. A. (2013) · Journal of Child and Family Studies · doi:10.1007/s10826-013-9742-1 · Cited by 49
Fear extinction and memory reconsolidation as critical components in behavioral treatment for posttraumatic stress disorder and potential augmentation of these processes
Smith, N. B., Doran, J. M., Sippel, L. M., & Harpaz-Rotem, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.006 · Cited by 46
D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach
MacKillop, J., Few, L. R., Stojek, M. M., Murphy, C. M., Malutinok, S. F., Johnson, F. T., Hofmann, S. G., McGeary, J. E., Swift, R. M., & Monti, P. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.41 · Cited by 46
Evidence-Based Assessment and Treatment of Specific Phobias in Adults
Hood, H. K., & Antony, M. M. (2012) · Autism and child psychopathology series · doi:10.1007/978-1-4614-3253-1_2 · Cited by 49
Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave, A. M., Tolin, D., & Stevens, M. (2012) · Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07564 · Cited by 48
Self-citation
INTRANASAL OXYTOCIN ADMINISTRATION PRIOR TO EXPOSURE THERAPY FOR ARACHNOPHOBIA IMPEDES TREATMENT RESPONSE: Research Article: Intranasal Oxytocin Administration
Acheson, D. T., Feifel, D., Kamenski, M., Mckinney, R., & Risbrough, V. B. (2015) · Depression and Anxiety · doi:10.1002/da.22362 · Cited by 44
Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias
Kamboj, S. K., Joye, A., Das, R. K., Gibson, A. J. W., Morgan, C. J. A., & Curran, H. V. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2571-2 · Cited by 44
Advances in pharmacotherapy for pediatric anxiety disorders
Rynn, M. A., Puliafico, A. C., Heleniak, C. M., Rikhi, P., Ghalib, K., & Vidair, H. B. (2011) · Depression and Anxiety · doi:10.1002/da.20769 · Cited by 45
Obsessive Compulsive Disorder: A Comparison of CBT and the Metacognitive Approach
Fisher, P. (2009) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2009.2.2.107 · Cited by 44
Anxiety disorders
Klein, R. G. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.02061.x · Cited by 49
Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders
Graham, B. M., Callaghan, B. L., & Richardson, R. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.012 · Cited by 49
Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF)
Bangasser, D. A., & Kawasumi, Y. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.04.003 · Cited by 46
The role of NMDA receptors in the signal attenuation rat model of obsessive–compulsive disorder
Albelda, N. S., Bar-On, N., & Joel, D. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1808-9 · Cited by 43
Effect size and statistical power in the rodent fear conditioning literature – A systematic review
Carneiro, C. F. D., Moulin, T. C., Macleod, M. R., & Amaral, O. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196258 · Cited by 48
Early Interventions Following Exposure to Traumatic Events: Implications for Practice From Recent Research
Dyregrov, A., & Regel, S. (2012) · Journal of Loss and Trauma · doi:10.1080/15325024.2011.616832 · Cited by 43
D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: a meta-analysis
Bürkner, P.-C., Bittner, N., Holling, H., & Buhlmann, U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173660 · Cited by 41
Optimizing behavior therapy for youth with Tourette’s disorder
Mcguire, J. F., Ginder, N. D., Ramsey, K. A., Essoe, J. K.-Y., Ricketts, E. J., McCracken, J. T., & Piacentini, J. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0762-4 · Cited by 41
Anxiety as a disorder of uncertainty: implications for understanding maladaptive anxiety, anxious avoidance, and exposure therapy
Brown, V. M., Price, R. B., & Dombrovski, A. Y. (2023) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-023-01080-w · Cited by 51
d-Cycloserine Facilitates Extinction of Cocaine Self-Administration in Rats
Thanos, P. K., Bermeo, C., Wang, G.-J., & Volkow, N. D. (2011) · Synapse · doi:10.1002/syn.20922 · Cited by 46
N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
Kantrowitz, J. T. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.003 · Cited by 40
Post-traumatic stress disorder: emerging concepts of pharmacotherapy
Baker, D. G., Nievergelt, C. M., & Risbrough, V. B. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902972494 · Cited by 39
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
GOFF, D. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160225154812 · Cited by 40
A selective review of glutamate pharmacological therapy in obsessive–compulsive and related disorders
Grados, M. A., Atkins, E., Kovacikova, G. I., & McVicar, E. L. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s58601 · Cited by 41
Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice
Salum, G. A., DeSousa, D. A., do Rosário, M. C., Pine, D. S., & Manfro, G. G. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-s108 · Cited by 46
Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of d-cycloserine in heavy drinkers
Kamboj, S. K., Massey-Chase, R. A., Rodney, L., Das, R., Almahdi, B., Curran, H. V., & Morgan, C. J. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2254-z · Cited by 39
From antipsychotic to anti-schizophrenia drugs: role of animal models
Geyer, M. A., Olivier, B., Joëls, M., & Kahn, R. S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.06.006 · Cited by 40
Angiotensin Regulation of Amygdala Response to Threat in High-Trait-Anxiety Individuals
Reinecke, A., Browning, M. D., Breteler, J. K., Kappelmann, N., Ressler, K. J., Harmer, C. J., & Craske, M. G. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.05.007 · Cited by 35
Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder
Kvale, G., Hansen, B. K. A., Hagen, K., Abramowitz, J. S., Børtveit, T., Craske, M. G., Franklin, M. E., Haseth, S., Himle, J. A., Hystad, S. W., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13249 · Cited by 38
Glutamate Modulators in the Treatment of Obsessive-Compulsive Disorder
Pittenger, C. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150602-06 · Cited by 41
The Treatment of Substance Use Disorders: Recent Developments and New Perspectives
Rosenthal, A., Ebrahimi, C., Wedemeyer, F., Romanczuk‐Seiferth, N., & Beck, A. (2022) · Neuropsychobiology · doi:10.1159/000525268 · Cited by 44

Authors: Norberg, M. M., Krystal, J. H., & Tolin, D. F.
Affiliations: Yale University (US)
Corresponding author: Tolin, David F.
ORCID: Norberg, Melissa M.
Krystal, John H.
Tolin, David F.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2008-06
Volume: 63
Issue: 12
Pages: 1118-1126
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2008.01.012
OpenAlex: W2159630298
Cited by: 510
References: 121
Citations by year: 2026: 10 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 15 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 28 · 2017: 28 · 2016: 23 · 2015: 50 · 2014: 37 · 2013: 53 · 2012: 51
FWCI: 3.80
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: D-cycloserine, fear extinction, exposure therapy, NMDA receptor agonist, anxiety disorders, fear memory consolidation, neuroplasticity, augmentation therapy, translational research
MeSH terms: Animals, Anxiety Disorders, Combined Modality Therapy, Cycloserine, Desensitization, Psychologic, Extinction, Psychological, Fear, Humans, Implosive Therapy, Neuronal Plasticity, Receptors, N-Methyl-D-Aspartate, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks